Cargando…

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis

BACKGROUND: Several studies suggest that metformin has the potential effect of reducing cancer risk. However, its survival benefit in patients with colorectal cancer (CRC) and diabetes is unknown. The aim of our study is to address the effect of metformin on outcomes for CRC based on a systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Zu-Bing, Zhang, Zhi-Jiang, Liu, Chen-Ying, Liu, Yun, Cui, Ang, Liang, Zhong-Lin, Wang, Guang-Hui, Cui, Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960145/ https://www.ncbi.nlm.nih.gov/pubmed/24647047 http://dx.doi.org/10.1371/journal.pone.0091818

Ejemplares similares

Correction: Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Publicado: (2014)

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
por: Zhou, Ping-Ting, et al.
Publicado: (2017)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016)

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer
por: Al Omari, Amal, et al.
Publicado: (2018)

Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
por: Zhang, Zhi-Jiang, et al.
Publicado: (2011)

Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis
por: Liu, Yun, et al.
Publicado: (2018)

Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis
por: Jiao, Yu, et al.
Publicado: (2022)

Prognostic value of IRF-2 expression in colorectal cancer
por: Mei, Zubing, et al.
Publicado: (2017)

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017)

Metformin therapy associated with survival benefit in lung cancer patients with diabetes
por: Wan, Guoxing, et al.
Publicado: (2016)

Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis
por: Hu, Jiao, et al.
Publicado: (2018)

The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)

Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017)

Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
por: Forouzandeh, Farshad, et al.
Publicado: (2014)

Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
por: Powell, Marta K., et al.
Publicado: (2019)

Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
por: Tang, Yun-Liang, et al.
Publicado: (2017)

The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer
por: Ying, Hou-Qun, et al.
Publicado: (2021)

Survival Benefit and Safety of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy
por: Yang, Kun, et al.
Publicado: (2014)

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus
por: Tarhini, Zeinab, et al.
Publicado: (2022)

The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
por: Xiao, Yao, et al.
Publicado: (2017)

Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis
por: Zhang, Junqiang, et al.
Publicado: (2020)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
por: Li, Xiaogang, et al.
Publicado: (2017)

The long-term survival benefits of high and low ligation of inferior mesenteric artery in colorectal cancer surgery: A review and meta-analysis
por: Singh, Dujanand, et al.
Publicado: (2017)

Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
por: Huang, Qi-You, et al.
Publicado: (2020)

Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
por: Mei, Z, et al.
Publicado: (2014)

The survival benefit and safety of No. 12a lymphadenectomy for gastric cancer patients with distal or total gastrectomy
por: Yang, Kun, et al.
Publicado: (2016)

Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials
por: Tang, Victoria, et al.
Publicado: (2015)

Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials
Publicado: (2015)

Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
por: Liu, Feifei, et al.
Publicado: (2016)

Metformin and Its Benefits for Various Diseases
por: Lv, Ziquan, et al.
Publicado: (2020)

Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
por: Wang, Yaodu, et al.
Publicado: (2017)

Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018)

Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies
por: Wang, Yining, et al.
Publicado: (2023)

Metformin and Colorectal Cancer Risk in Diabetic Patients
por: Ioannou, George N., et al.
Publicado: (2011)

Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis
por: Luo, Cui-Song, et al.
Publicado: (2019)

Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials
por: Jonker, D J, et al.
Publicado: (2000)

The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
por: Li, Yang, et al.
Publicado: (2017)

The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study
por: Chu, Ping-Teng, et al.
Publicado: (2023)

Survival Benefits of Western and Traditional Chinese Medicine Treatment for Patients With Pancreatic Cancer
por: Yang, Xue, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f1fptjoj7tckiah66sq79jcfef